Page 6,300«..1020..6,2996,3006,3016,302..6,3106,320..»

New MS drug is 'most effective'

Posted: Published on November 2nd, 2012

1 November 2012 Last updated at 05:03 ET By James Gallagher Health and science reporter, BBC News A new drug is the "most effective" treatment for relapsing-remitting multiple sclerosis, say UK researchers. During MS the body's immune system turns on its own nerves causing debilitating muscle problems. Researchers at the University of Cambridge say a cancer drug, which wipes out and resets the immune system, has better results than other options. However, there is concern that a drugs company is about to increase the cost of the drug as a result. Around 100,000 people in the UK have multiple sclerosis. When the condition is diagnosed most will have a form of the disease know as relapsing-remitting MS, in which the symptoms can almost disappear for a time, before suddenly returning. The researchers tested a leukaemia drug, alemtuzumab, which had shown benefits for MS in small studies. In leukaemia, a blood cancer, it controls the excess production of white blood cells. In MS patients, the dose eliminates the immune cells entirely, forcing a new immune system to be built from scratch which should not attack the nerves. Two trials, published in the Lancet medical journal, compared the effectiveness of alemtuzumab with … Continue reading →

Posted in MS Treatment | Comments Off on New MS drug is 'most effective'

Drug 'effective treatment' for MS

Posted: Published on November 2nd, 2012

A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found. The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS. The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared with the current drug interferon beta-1a which is known commercially as Rebif. This result was seen both in patients who had not previously received any treatment and those who have continued to show disease activity while taking an existing treatment for MS, found the study published in the journal The Lancet. In one trial with patients who had recently relapsed, new episodes were reduced by 49% more than that achieved by the current standard treatment. Over a two-year period, 65% of patients on alemtuzumab compared with 47% of patients on interferon did not relapse. The study, sponsored by Genzyme and Bayer Schering Pharma, found that alemtuzumab also reduced the risk of acquiring disability by 42% compared with interferon. Disability worsened in 20% of interferon … Continue reading →

Posted in MS Treatment | Comments Off on Drug 'effective treatment' for MS

Leukemia Drug Is Highly Effective MS Treatment

Posted: Published on November 2nd, 2012

Alemtuzumab Lessens Relapses, Improves Disability By Salynn Boyles WebMD Health News Reviewed by Louise Chang, MD Oct. 31, 2012 -- Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment. When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduced relapse rates by half, researchers say. Alemtuzumab has been used to treat MS for close to two decades, but it has never been approved for this use. It is given by IV infusion. The drug not only reduced relapses, but improved disability associated with MS, such as loss of coordination or difficulty walking, in some patients. Side effects include infusion reactions, infections, and potentially serious autoimmune disorders. Patients taking it must be followed closely. "In the menu of treatment choices for MS patients, I think alemtuzumab falls into the 'high-reward, high-risk' category," says Alasdair Coles, MD, of Britain's University of Cambridge, who led one of the newly published studies. "No other drug has been shown to offer the benefits in terms of disability improvement that this drug shows," he says. "It comes with problems, but these problems are manageable." Read the original post: Leukemia Drug … Continue reading →

Posted in MS Treatment | Comments Off on Leukemia Drug Is Highly Effective MS Treatment

Global Market for Neurodegenerative Disorder Treatments to Reach $23.5 billion in 2017, Weakness Disorders Treatments …

Posted: Published on November 2nd, 2012

FARMINGTON, Conn., Oct. 31, 2012 /PRNewswire-iReach/ -- Learn about the global market for progressive ataxia and weakness disorder treatments and the factors that will influence the long-term development of neurodegenerative disorders in the pharmaceutical and biotechnology markets; learnabout the treatments that are most likely to be commercialized in the next five years. (Photo: http://photos.prnewswire.com/prnh/20121031/CG03571) Global Information Inc (GII) is announces the availability of four significant market research reports from our premium research partner BCC Research. Pharmaceutical biotechnical companies, research institutes and physicians will find these new studies to be of interest. Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders The global market for treatments for syndromes of progressive ataxia and weakness disorders was valued at nearly $14 billion in 2011 and should reach nearly $15 billion in 2012. Total market value is expected to reach nearly $23.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 9.4%. Key areas of growth in the neurodegenerative disorder market include: Friedreich's ataxia, Gerstmann-Straussler-Scheinker disease, Machado-Joseph disease, amyotrophic lateral sclerosis, progressive bulbar palsy, hereditary spastic paraplegia, hereditary neuropathies and multiple sclerosis. The report discusses applications for neurodegenerative disorder treatment and therapy technologies, with emphasis on … Continue reading →

Comments Off on Global Market for Neurodegenerative Disorder Treatments to Reach $23.5 billion in 2017, Weakness Disorders Treatments …

Cord Blood Banking | Benefits Of Cord Blood Banking – Video

Posted: Published on November 2nd, 2012

Cord Blood Banking | Benefits Of Cord Blood Banking http://www.cordbloodrecommendation.com If you are pregnant, you probably have received information about cord blood banking. This is an opportunity for you to bank your child's umbilical cord blood. When cord blood is banked, it is stored so that at a later time, it can be used when needed. There are several key reasons why anyone should consider cord blood banking. Cord blood contains very important cells that can help to grow a healthy immune system for someone who has fallen ill. Not only can this cord blood be used for your child, but for others that have the same type of blood and tissue. Although cord blood banking is expensive when done privately, it can be life saving and this is often the reason to consider it. Cord blood stem cells can be used to treat diseases and conditions such as leukemia, myelodysplastic syndrome, anemia, sickle cell disease, inherited red cell abnormality, lymphoma, plasma cell disorder, neuroblastoma and myeloma. Today, there are over 75 different diseases, immune deficiencies and other conditions that are treated with cord blood successfully. With the advancement of stem cell research, there is likely to be more … Continue reading →

Posted in Stem Cell Research | Comments Off on Cord Blood Banking | Benefits Of Cord Blood Banking – Video

Facebook Strings with Right Wingers and Embryonic Stem Cell Research – Video

Posted: Published on November 2nd, 2012

Facebook Strings with Right Wingers and Embryonic Stem Cell Research If you disagree with conservatives they can get very enraged, almost crazy mad at you.From:jeffreydebra1Views:8 1ratingsTime:08:18More inPeople Blogs Go here to read the rest: Facebook Strings with Right Wingers and Embryonic Stem Cell Research - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Facebook Strings with Right Wingers and Embryonic Stem Cell Research – Video

Our Stem Cell Future: What’s Next? – Larry Goldstein UCSD – Video

Posted: Published on November 2nd, 2012

Our Stem Cell Future: What's Next? - Larry Goldstein UCSD Larry Goldstein, director of the UC San Diego Stem Cell Program, speculates about the future of stem cell therapies. To learn about the efforts of California's Stem Cell Agency (CIRM) to accelerate the development of new therapies for chronic disease and injury, visit our home page at: http://www.cirm.ca.govFrom:CIRMTVViews:24 2ratingsTime:02:57More inScience Technology Go here to read the rest: Our Stem Cell Future: What's Next? - Larry Goldstein UCSD - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Our Stem Cell Future: What’s Next? – Larry Goldstein UCSD – Video

Research Round Table 2012 – Caroline Tanner, MD, PhD, Director of Clinical Research, TPI – Video

Posted: Published on November 2nd, 2012

Research Round Table 2012 - Caroline Tanner, MD, PhD, Director of Clinical Research, TPI Here at The Parkinson's Institute, we don't only have a nationally-recognized clinic and treat thousands of patients a year, but we also have exciting laboratories that work directly with Parkinson's disease and are discovering new things about the disease every day. From stem cell research to genetic mutations, hear from each of our labs about the latest findings from our brilliant scientists.From:ParkinsonInstituteViews:0 0ratingsTime:15:25More inScience Technology Read more from the original source: Research Round Table 2012 - Caroline Tanner, MD, PhD, Director of Clinical Research, TPI - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Research Round Table 2012 – Caroline Tanner, MD, PhD, Director of Clinical Research, TPI – Video

Research Round Table 2012 – Question and Answer Session – Video

Posted: Published on November 2nd, 2012

Research Round Table 2012 - Question and Answer Session Here at The Parkinson's Institute, we don't only have a nationally-recognized clinic and treat thousands of patients a year, but we also have exciting laboratories that work directly with Parkinson's disease and are discovering new things about the disease every day. From stem cell research to genetic mutations, hear from each of our labs about the latest findings from our brilliant scientists.From:ParkinsonInstituteViews:0 0ratingsTime:16:16More inScience Technology Originally posted here: Research Round Table 2012 - Question and Answer Session - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Research Round Table 2012 – Question and Answer Session – Video

Research Round Table 2012 – Birgitt Schuele, MD, Assistant Professor, Clinical Molecular Geneticist – Video

Posted: Published on November 2nd, 2012

Research Round Table 2012 - Birgitt Schuele, MD, Assistant Professor, Clinical Molecular Geneticist Here at The Parkinson's Institute, we don't only have a nationally-recognized clinic and treat thousands of patients a year, but we also have exciting laboratories that work directly with Parkinson's disease and are discovering new things about the disease every day. From stem cell research to genetic mutations, hear from each of our labs about the latest findings from our brilliant scientists.From:ParkinsonInstituteViews:0 0ratingsTime:12:06More inScience Technology Read the original here: Research Round Table 2012 - Birgitt Schuele, MD, Assistant Professor, Clinical Molecular Geneticist - Video … Continue reading →

Posted in Stem Cell Research | Comments Off on Research Round Table 2012 – Birgitt Schuele, MD, Assistant Professor, Clinical Molecular Geneticist – Video

Page 6,300«..1020..6,2996,3006,3016,302..6,3106,320..»